Page last updated: 2024-10-24

celecoxib and Scleritis

celecoxib has been researched along with Scleritis in 1 studies

Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.

Research Excerpts

ExcerptRelevanceReference
"Due to its anti-inflammatory potency and low rate of side effects, celecoxib is an effective drug for the treatment of diffuse anterior scleritis."7.73Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. ( Bauer, AM; Becker, MD; Fiehn, C, 2005)
"Due to its anti-inflammatory potency and low rate of side effects, celecoxib is an effective drug for the treatment of diffuse anterior scleritis."3.73Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. ( Bauer, AM; Becker, MD; Fiehn, C, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, AM1
Fiehn, C1
Becker, MD1

Other Studies

1 other study available for celecoxib and Scleritis

ArticleYear
Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis.
    American journal of ophthalmology, 2005, Volume: 139, Issue:6

    Topics: Adult; Aged; Anterior Eye Segment; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Male; Middl

2005